ArticleJournal of clinical medicine2025

First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data.

Mehmet Cem Fidan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.